Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: Insights from the Canadian Acute Coronary Syndrome Registries

American Heart Journal

Volumn 150, Issue 4, 2005, Pages 690-694

  Segev, Amit ^a   Strauss, Bradley H ^a   Tan, Mary ^b   Constance, Christian ^c   Langer, Anatoly ^a,b   Goodman, Shaun G ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CANADIAN HEART RESEARCH CENTRE   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

ADULT; ARTICLE; BLEEDING; BYPASS SURGERY; CATHETERIZATION; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT; PREDICTION; PRIORITY JOURNAL; REGISTER; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; STROKE; THROMBOSIS;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; ELECTROCARDIOGRAPHY; FEMALE; HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; REGISTRIES; SYNDROME; TIME FACTORS;

EID: 25844504265     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.11.012     Document Type: Article

References (11)

1. S. Rasty, S. Borzak, and J.E. Tisdale Bleeding associated with eptifibatide targeting higher risk patients with acute coronary syndromes: incidence and multivariate risk factors J Clin Pharmacol 42 2002 1366 1373
2. M. Moscucci, K.A. Fox, and C.P. Cannon Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
3. J.P. Collet, G. Montalescot, and E. Fine Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials J Am Coll Cardiol 41 2003 8 14
4. T. Lenderink, E. Boersma, and W. Ruzyllo Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV-ACS Am Heart J 147 2004 865 873
5. C.W. Hamm, C. Heeschen, and B. Goldmann Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators N Engl J Med 340 1999 1623 1629
6. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
7. H.M. Sadeghi, C.L. Grines, and H.R. Chandra Percutaneous coronary interventions in octogenarians: glycoprotein IIb/IIIa receptor inhibitors' safety profile J Am Coll Cardiol 42 2003 428 432
8. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
9. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
10. S.R. Mehta, and S. Yusuf Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention J Am Coll Cardiol 41 Suppl. S 2003 79S 88S
11. H. Jneid, D.L. Bhatt, and R. Corti Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study Arch Intern Med 163 2003 1145 1153